Published in Br J Ophthalmol on December 03, 2009
Mechanisms of age-related macular degeneration. Neuron (2012) 2.62
Immunology of age-related macular degeneration. Nat Rev Immunol (2013) 2.14
Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks. Genome Med (2012) 1.46
Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration. Invest Ophthalmol Vis Sci (2011) 1.30
Aging is not a disease: distinguishing age-related macular degeneration from aging. Prog Retin Eye Res (2013) 1.29
Programmed necrosis, not apoptosis, is a key mediator of cell loss and DAMP-mediated inflammation in dsRNA-induced retinal degeneration. Cell Death Differ (2013) 1.23
Genome-wide association study of age-related macular degeneration identifies associated variants in the TNXB-FKBPL-NOTCH4 region of chromosome 6p21.3. Hum Mol Genet (2012) 1.18
Dry age-related macular degeneration: mechanisms, therapeutic targets, and imaging. Invest Ophthalmol Vis Sci (2013) 1.17
Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy. Prog Retin Eye Res (2014) 1.17
Dietary hyperglycemia, glycemic index and metabolic retinal diseases. Prog Retin Eye Res (2010) 1.06
Myeloid cells expressing VEGF and arginase-1 following uptake of damaged retinal pigment epithelium suggests potential mechanism that drives the onset of choroidal angiogenesis in mice. PLoS One (2013) 1.04
T cells and macrophages responding to oxidative damage cooperate in pathogenesis of a mouse model of age-related macular degeneration. PLoS One (2014) 1.01
Seeing through VEGF: innate and adaptive immunity in pathological angiogenesis in the eye. Trends Mol Med (2014) 1.00
Recent developments in the treatment of age-related macular degeneration. J Clin Invest (2014) 0.99
Small interfering RNA-mediated suppression of Ccl2 in Müller cells attenuates microglial recruitment and photoreceptor death following retinal degeneration. J Neuroinflammation (2012) 0.98
Chemokine-mediated inflammation in the degenerating retina is coordinated by Müller cells, activated microglia, and retinal pigment epithelium. J Neuroinflammation (2015) 0.96
Early focal expression of the chemokine Ccl2 by Müller cells during exposure to damage-inducing bright continuous light. Invest Ophthalmol Vis Sci (2011) 0.96
Abundance of infiltrating CD163+ cells in the retina of postmortem eyes with dry and neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2015) 0.93
Eyeballing cholesterol efflux and macrophage function in disease pathogenesis. Trends Endocrinol Metab (2013) 0.92
Natural history of age-related retinal lesions that precede AMD in mice fed high or low glycemic index diets. Invest Ophthalmol Vis Sci (2012) 0.90
The unfolded protein response in retinal vascular diseases: implications and therapeutic potential beyond protein folding. Prog Retin Eye Res (2014) 0.89
Fcγ receptor upregulation is associated with immune complex inflammation in the mouse retina and early age-related macular degeneration. Invest Ophthalmol Vis Sci (2014) 0.87
Expression of neonatal Fc receptor in the eye. Invest Ophthalmol Vis Sci (2014) 0.87
Bowman lecture on the role of inflammation in degenerative disease of the eye. Eye (Lond) (2013) 0.84
Oxidative stress, innate immunity, and age-related macular degeneration. AIMS Mol Sci (2016) 0.83
Molecular pathology of macrophages and interleukin-17 in age-related macular degeneration. Adv Exp Med Biol (2014) 0.83
Alterations in Circulating Immune Cells in Neovascular Age-Related Macular Degeneration. Sci Rep (2015) 0.83
Prevalence of anti-retinal autoantibodies in different stages of Age-related macular degeneration. BMC Ophthalmol (2014) 0.82
Regulation of age-related macular degeneration-like pathology by complement factor H. Proc Natl Acad Sci U S A (2015) 0.82
Vascular associations and dynamic process motility in perivascular myeloid cells of the mouse choroid: implications for function and senescent change. Invest Ophthalmol Vis Sci (2014) 0.82
Drusen regression is associated with local changes in fundus autofluorescence in intermediate age-related macular degeneration. Am J Ophthalmol (2013) 0.81
Emerging roles for nuclear receptors in the pathogenesis of age-related macular degeneration. Cell Mol Life Sci (2014) 0.80
Synthesis and propagation of complement C3 by microglia/monocytes in the aging retina. PLoS One (2014) 0.80
VISUALIZING RETINAL PIGMENT EPITHELIUM PHENOTYPES IN THE TRANSITION TO GEOGRAPHIC ATROPHY IN AGE-RELATED MACULAR DEGENERATION. Retina (2016) 0.80
Distribution and Quantification of Choroidal Macrophages in Human Eyes With Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci (2016) 0.79
The retinal pigment epithelium (RPE) induces FasL and reduces iNOS and Cox2 in primary monocytes. Graefes Arch Clin Exp Ophthalmol (2014) 0.79
The role of macrophage class a scavenger receptors in a laser-induced murine choroidal neovascularization model. Invest Ophthalmol Vis Sci (2013) 0.79
CFH Y402H polymorphism is associated with elevated vitreal GM-CSF and choroidal macrophages in the postmortem human eye. Mol Vis (2015) 0.78
Spatiotemporal Cadence of Macrophage Polarisation in a Model of Light-Induced Retinal Degeneration. PLoS One (2015) 0.78
Intravitreal sirolimus for the treatment of geographic atrophy: results of a phase I/II clinical trial. Invest Ophthalmol Vis Sci (2014) 0.78
Chronologic versus biologic aging of the human choroid. ScientificWorldJournal (2013) 0.78
Lipids, oxidized lipids, oxidation-specific epitopes, and Age-related Macular Degeneration. Biochim Biophys Acta (2016) 0.76
The broad-spectrum chemokine inhibitor NR58-3.14.3 modulates macrophage-mediated inflammation in the diseased retina. J Neuroinflammation (2016) 0.76
Loss of CD34 expression in aging human choriocapillaris endothelial cells. PLoS One (2014) 0.76
Absence of DJ-1 causes age-related retinal abnormalities in association with increased oxidative stress. Free Radic Biol Med (2017) 0.75
Gene Therapy with Endogenous Inhibitors of Angiogenesis for Neovascular Age-Related Macular Degeneration: Beyond Anti-VEGF Therapy. J Ophthalmol (2015) 0.75
A Revised Hemodynamic Theory of Age-Related Macular Degeneration. Trends Mol Med (2016) 0.75
AIF-independent parthanatos in the pathogenesis of dry age-related macular degeneration. Cell Death Dis (2017) 0.75
Structural and molecular changes in the aging choroid: implications for age-related macular degeneration. Eye (Lond) (2016) 0.75
Myeloid-Specific Blockade of Notch Signaling Attenuates Choroidal Neovascularization through Compromised Macrophage Infiltration and Polarization in Mice. Sci Rep (2016) 0.75
Fucoidan as a Potential Therapeutic for Major Blinding Diseases-A Hypothesis. Mar Drugs (2016) 0.75
Relationships of orientation discrimination threshold and visual acuity with macular lesions in age-related macular degeneration. PLoS One (2017) 0.75
Macrophage physiology in the eye. Pflugers Arch (2017) 0.75
Ageing and degeneration in the macular region: a clinico-pathological study. Br J Ophthalmol (1976) 5.73
Evolution of geographic atrophy of the retinal pigment epithelium. Eye (Lond) (1988) 4.47
Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res (2001) 2.87
New vessel formation beneath the retinal pigment epithelium in senile eyes. Br J Ophthalmol (1973) 2.43
Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up. Aust N Z J Ophthalmol (1998) 2.20
Council Lecture. Drusen and their relationship to senile macular degeneration. Aust J Ophthalmol (1980) 2.08
Swelling and loss of photoreceptors in chronic human and experimental glaucomas. Arch Ophthalmol (2000) 1.89
Reticular pseudodrusen. A risk factor in age-related maculopathy. Retina (1995) 1.88
Macrophages related to Bruch's membrane in age-related macular degeneration. Eye (Lond) (1990) 1.87
Morphology of early choroidal neovascularisation in age-related macular degeneration: correlation with activity. Eye (Lond) (1997) 1.80
Senile macular degeneration: the involvement of immunocompetent cells. Graefes Arch Clin Exp Ophthalmol (1985) 1.66
Evolution of soft drusen in age-related macular degeneration. Eye (Lond) (1994) 1.54
Indocyanine green angiography of drusen. Am J Ophthalmol (1997) 1.47
Physician payment reform: anesthesiology as a case study. Anesthesiology (1990) 1.43
Standards. Aust N Z J Ophthalmol (1996) 1.39
Pseudo-endophthalmitis after intravitreal injection of triamcinolone. Br J Ophthalmol (2003) 1.27
The Medicare Economic Index: its background and beginnings. Health Care Financ Rev (1981) 1.26
Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: implications for macular degeneration. Clin Exp Immunol (2000) 1.25
Extracts from "clinical evidence": age related macular degeneration. BMJ (2000) 1.22
Softening of drusen and subretinal neovascularization. Trans Ophthalmol Soc U K (1980) 1.20
Treatment of choroidal neovascularisation in age-related macular degeneration with interferon alfa-2a and alfa-2b. Br J Ophthalmol (1993) 1.15
The comparative biology of neuromelanin and lipofuscin in the human brain. Cell Mol Life Sci (2008) 1.13
Senile macular degeneration. The involvement of giant cells in atrophy of the retinal pigment epithelium. Invest Ophthalmol Vis Sci (1986) 1.05
Future research and policy directions in physician reimbursement. Health Care Financ Rev (1981) 0.97
Bilateral carotid body tumors managed with preoperative embolization: a case report and review. J Vasc Surg (1987) 0.96
Adult vitelliform macular degeneration: a clinicopathological study. Eye (Lond) (2003) 0.92
Distribution of cathepsin D in human eyes with or without age-related maculopathy. Exp Eye Res (1999) 0.91
Pharyngoesophageal perforation after blunt neck trauma. Ann Thorac Surg (1990) 0.90
Lung morphometry and collagen and elastin content: changes during normal development and after prenatal hormone exposure in sheep. Pediatr Res (1999) 0.89
Drusen patterns predisposing to geographic atrophy of the retinal pigment epithelium. Aust J Ophthalmol (1982) 0.87
A case of idiopathic perifoveal Telangiectasia preceded by features of cone dystrophy. Eye (Lond) (2007) 0.84
What determines the site of inflammation in uveitis and chorioretinitis? Eye (Lond) (1997) 0.82
Triamcinolone acetonide inhibits p38MAPK activation and neuronal apoptosis in early diabetic retinopathy. Curr Mol Med (2013) 0.82
Diabetes impairs mobilization of mouse bone marrow-derived Lin(-)/VEGF-R2(+) progenitor cells. Blood Cells Mol Dis (2013) 0.80
Adult vitelliform macular degeneration: a clinical spectrum. Aust N Z J Ophthalmol (1990) 0.80
What price, Medicare? Geographic variability in Medicare physician payment levels. Inquiry (1990) 0.78
The fellow eye in senile disciform degeneration. Trans Aust Coll Ophthalmol (1970) 0.78
Conditioned medium from mixed retinal pigmented epithelium and Müller cell cultures reduces in vitro permeability of retinal vascular endothelial cells. Br J Ophthalmol (2004) 0.78
Schwann cells cultured from adult rats contain a cytoskeletal protein related to astrocyte filaments. Brain Res (1985) 0.78
Senile choroidal sclerosis. Br J Ophthalmol (1973) 0.77
Effect of topical interferon-alpha 2b on corneal haze after excimer laser photorefractive keratectomy in rabbits. Refract Corneal Surg (1994) 0.76
Detection and treatment of diabetic retinopathy. Clin Experiment Ophthalmol (2001) 0.75
A study of gastroenterologists in the United States. Am J Gastroenterol (1991) 0.75
What do economists think patients want? Health Aff (Millwood) (1990) 0.75
Putting power into patient choice. N Engl J Med (1999) 0.75
The aging eye. Med J Aust (1975) 0.75
An analysis of methods to reform Medicare payment for physician services. Inquiry (1987) 0.75
A crime story from Medicare Part B. Health Aff (Millwood) (1988) 0.75
Investigation of the lipid component of neuromelanin. J Neural Transm (Vienna) (2006) 0.75
Medicare part B carrier approved charges in 1988. Health Aff (Millwood) (1989) 0.75
Understanding the tides of physician payment reform. Interview by C. Burns Roehrig. Internist (1990) 0.75
A simple method for the in vitro culture of human retinal capillary endothelial cells. Invest Ophthalmol Vis Sci (1992) 0.75
Treatment of macular degeneration--controversy and hope. Br J Ophthalmol (2008) 0.75
Medicare Part B: rising assignment rates, rising costs. Inquiry (1987) 0.75